S
Steven A. Pergam
Researcher at Fred Hutchinson Cancer Research Center
Publications - 152
Citations - 5450
Steven A. Pergam is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 27, co-authored 133 publications receiving 4266 citations. Previous affiliations of Steven A. Pergam include University of Washington & University of New Mexico.
Papers
More filters
Journal ArticleDOI
Reduced mortality after allogeneic hematopoietic-cell transplantation.
Ted Gooley,Jason W. Chien,Jason W. Chien,Steven A. Pergam,Steven A. Pergam,Sangeeta Hingorani,Sangeeta Hingorani,Mohamed L. Sorror,Mohamed L. Sorror,Michael Boeckh,Michael Boeckh,Paul J. Martin,Paul J. Martin,Brenda M. Sandmaier,Brenda M. Sandmaier,Kieren A. Marr,Kieren A. Marr,Frederick R. Appelbaum,Frederick R. Appelbaum,Rainer Storb,Rainer Storb,George B. McDonald,George B. McDonald +22 more
TL;DR: A substantial reduction in the hazard of death related to allogeneic hematopoietic-cell transplantation, as well as increased long-term survival, over the past decade is found.
Journal ArticleDOI
Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal
Masumi Ueda,Masumi Ueda,Masumi Ueda,Renato G. Martins,Renato G. Martins,Renato G. Martins,Paul C. Hendrie,Paul C. Hendrie,Paul C. Hendrie,Terry McDonnell,Jennie R Crews,Jennie R Crews,Tracy Wong,Brittany McCreery,Barbara Jagels,Aaron Crane,David R. Byrd,David R. Byrd,Steven A. Pergam,Steven A. Pergam,Steven A. Pergam,Nancy E. Davidson,Nancy E. Davidson,Nancy E. Davidson,Catherine Liu,Catherine Liu,Catherine Liu,F. Marc Stewart,F. Marc Stewart,F. Marc Stewart +29 more
TL;DR: This Special Feature highlights the unique circumstances and challenges of cancer treatment amidst this global pandemic, and the importance of organizational structure, preparation, agility, and a shared vision for continuing to provide cancer treatment to patients in the face of uncertainty and rapid change.
Journal ArticleDOI
West Nile virus neuroinvasive disease.
Larry E. Davis,Roberta L. DeBiasi,Diane Goade,Kathleen Y. Haaland,Jennifer A. Harrington,JoAnn Harnar,Steven A. Pergam,Molly K. King,Bette K. DeMasters,Kenneth L. Tyler +9 more
TL;DR: Recent studies suggest that some WNV‐infected patients have persistent WNV IgM serum and/or cerebrospinal fluid antibody responses, and this may require revision of current serodiagnostic criteria.
Journal ArticleDOI
Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use
Steven A. Pergam,Maresa C. Woodfield,Christine M. Lee,Guang‐Shing Cheng,Kelsey Baker,Sara Marquis,Jesse R. Fann +6 more
TL;DR: This study was designed to determine the prevalence and methods of use among cancer patients, the perceived benefits, and the sources of information in a state with legalized cannabis.
Journal ArticleDOI
Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients.
Diana F. Florescu,Steven A. Pergam,Steven A. Pergam,Michael Neely,Fang Qiu,Christine Johnston,Christine Johnston,Sing Sing Way,Jane Sande,Deborah A. Lewinsohn,Judith A. Guzman-Cottrill,M. Graham,Genovefa A. Papanicolaou,Joanne Kurtzberg,Joseph Rigdon,Wendy Painter,Herve Mommeja-Marin,Randall Lanier,Maggie Anderson,Charles van der Horst +19 more
TL;DR: CMX001 may be a promising therapeutic option for the treatment of severe adenovirus disease in immunocompromised patients and had longer survival than those without VR.